ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
TBX1
|
ENSG00000184058.8 | TBX1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TBX1 | hg19_v2_chr22_+_19744226_19744226 | -0.48 | 6.1e-02 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr17_-_7080227 | 3.27 |
ENST00000574330.1 |
ASGR1 |
asialoglycoprotein receptor 1 |
chr6_-_160166218 | 3.02 |
ENST00000537657.1 |
SOD2 |
superoxide dismutase 2, mitochondrial |
chr14_+_95078714 | 2.74 |
ENST00000393078.3 ENST00000393080.4 ENST00000467132.1 |
SERPINA3 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
chr15_-_79237433 | 2.67 |
ENST00000220166.5 |
CTSH |
cathepsin H |
chr19_-_9731872 | 2.46 |
ENST00000424629.1 ENST00000326044.5 ENST00000354661.4 ENST00000435550.1 ENST00000444611.1 ENST00000421525.1 |
ZNF561 |
zinc finger protein 561 |
chrX_-_133119476 | 2.37 |
ENST00000543339.1 |
GPC3 |
glypican 3 |
chr2_+_228678550 | 2.36 |
ENST00000409189.3 ENST00000358813.4 |
CCL20 |
chemokine (C-C motif) ligand 20 |
chr17_+_53343577 | 2.29 |
ENST00000573945.1 |
HLF |
hepatic leukemia factor |
chr12_-_53594227 | 2.26 |
ENST00000550743.2 |
ITGB7 |
integrin, beta 7 |
chr2_+_75061108 | 2.12 |
ENST00000290573.2 |
HK2 |
hexokinase 2 |
chr10_+_94451574 | 2.01 |
ENST00000492654.2 |
HHEX |
hematopoietically expressed homeobox |
chr11_-_33913708 | 2.00 |
ENST00000257818.2 |
LMO2 |
LIM domain only 2 (rhombotin-like 1) |
chr2_+_219283815 | 1.99 |
ENST00000248444.5 ENST00000454069.1 ENST00000392114.2 |
VIL1 |
villin 1 |
chr21_-_15918618 | 1.99 |
ENST00000400564.1 ENST00000400566.1 |
SAMSN1 |
SAM domain, SH3 domain and nuclear localization signals 1 |
chr16_-_55866997 | 1.91 |
ENST00000360526.3 ENST00000361503.4 |
CES1 |
carboxylesterase 1 |
chr16_+_12058961 | 1.86 |
ENST00000053243.1 |
TNFRSF17 |
tumor necrosis factor receptor superfamily, member 17 |
chr16_+_12059050 | 1.85 |
ENST00000396495.3 |
TNFRSF17 |
tumor necrosis factor receptor superfamily, member 17 |
chr10_+_114135952 | 1.85 |
ENST00000356116.1 ENST00000433418.1 ENST00000354273.4 |
ACSL5 |
acyl-CoA synthetase long-chain family member 5 |
chr20_-_22565101 | 1.84 |
ENST00000419308.2 |
FOXA2 |
forkhead box A2 |
chr10_+_114135004 | 1.80 |
ENST00000393081.1 |
ACSL5 |
acyl-CoA synthetase long-chain family member 5 |
chr19_-_10450328 | 1.69 |
ENST00000160262.5 |
ICAM3 |
intercellular adhesion molecule 3 |
chr12_-_8025499 | 1.65 |
ENST00000431042.2 |
SLC2A14 |
solute carrier family 2 (facilitated glucose transporter), member 14 |
chr4_+_128554081 | 1.65 |
ENST00000335251.6 ENST00000296461.5 |
INTU |
inturned planar cell polarity protein |
chr2_-_169769787 | 1.64 |
ENST00000451987.1 |
SPC25 |
SPC25, NDC80 kinetochore complex component |
chr19_-_7764281 | 1.64 |
ENST00000360067.4 |
FCER2 |
Fc fragment of IgE, low affinity II, receptor for (CD23) |
chr7_-_150675372 | 1.64 |
ENST00000262186.5 |
KCNH2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
chr15_-_80263506 | 1.62 |
ENST00000335661.6 |
BCL2A1 |
BCL2-related protein A1 |
chr1_-_161193349 | 1.60 |
ENST00000469730.2 ENST00000463273.1 ENST00000464492.1 ENST00000367990.3 ENST00000470459.2 ENST00000468465.1 ENST00000463812.1 |
APOA2 |
apolipoprotein A-II |
chr16_+_12059091 | 1.60 |
ENST00000562385.1 |
TNFRSF17 |
tumor necrosis factor receptor superfamily, member 17 |
chr8_+_56014949 | 1.60 |
ENST00000327381.6 |
XKR4 |
XK, Kell blood group complex subunit-related family, member 4 |
chr16_-_88717423 | 1.60 |
ENST00000568278.1 ENST00000569359.1 ENST00000567174.1 |
CYBA |
cytochrome b-245, alpha polypeptide |
chrX_-_154563889 | 1.60 |
ENST00000369449.2 ENST00000321926.4 |
CLIC2 |
chloride intracellular channel 2 |
chrX_-_52260199 | 1.54 |
ENST00000375600.1 |
XAGE1A |
X antigen family, member 1A |
chr1_-_169555779 | 1.53 |
ENST00000367797.3 ENST00000367796.3 |
F5 |
coagulation factor V (proaccelerin, labile factor) |
chrX_+_49216659 | 1.47 |
ENST00000415752.1 |
GAGE12I |
G antigen 12I |
chr14_-_106406090 | 1.46 |
ENST00000390593.2 |
IGHV6-1 |
immunoglobulin heavy variable 6-1 |
chr17_-_38721711 | 1.43 |
ENST00000578085.1 ENST00000246657.2 |
CCR7 |
chemokine (C-C motif) receptor 7 |
chr16_-_88717482 | 1.43 |
ENST00000261623.3 |
CYBA |
cytochrome b-245, alpha polypeptide |
chr11_+_60223312 | 1.40 |
ENST00000532491.1 ENST00000532073.1 ENST00000534668.1 ENST00000528313.1 ENST00000533306.1 |
MS4A1 |
membrane-spanning 4-domains, subfamily A, member 1 |
chr11_+_60223225 | 1.39 |
ENST00000524807.1 ENST00000345732.4 |
MS4A1 |
membrane-spanning 4-domains, subfamily A, member 1 |
chr12_-_54691668 | 1.38 |
ENST00000553198.1 |
NFE2 |
nuclear factor, erythroid 2 |
chr19_+_10397648 | 1.37 |
ENST00000340992.4 ENST00000393717.2 |
ICAM4 |
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) |
chr11_+_73358594 | 1.35 |
ENST00000227214.6 ENST00000398494.4 ENST00000543085.1 |
PLEKHB1 |
pleckstrin homology domain containing, family B (evectins) member 1 |
chr12_+_69742121 | 1.33 |
ENST00000261267.2 ENST00000549690.1 ENST00000548839.1 |
LYZ |
lysozyme |
chr8_-_124428569 | 1.32 |
ENST00000521903.1 |
ATAD2 |
ATPase family, AAA domain containing 2 |
chr3_+_167453493 | 1.32 |
ENST00000295777.5 ENST00000472747.2 |
SERPINI1 |
serpin peptidase inhibitor, clade I (neuroserpin), member 1 |
chr20_+_30640004 | 1.30 |
ENST00000520553.1 ENST00000518730.1 ENST00000375852.2 |
HCK |
hemopoietic cell kinase |
chr8_-_61880248 | 1.29 |
ENST00000525556.1 |
AC022182.3 |
AC022182.3 |
chr19_+_45409011 | 1.29 |
ENST00000252486.4 ENST00000446996.1 ENST00000434152.1 |
APOE |
apolipoprotein E |
chr12_+_32112340 | 1.29 |
ENST00000540924.1 ENST00000312561.4 |
KIAA1551 |
KIAA1551 |
chr17_+_80416050 | 1.27 |
ENST00000579198.1 ENST00000390006.4 ENST00000580296.1 |
NARF |
nuclear prelamin A recognition factor |
chr1_-_24194771 | 1.27 |
ENST00000374479.3 |
FUCA1 |
fucosidase, alpha-L- 1, tissue |
chr4_-_155511887 | 1.26 |
ENST00000302053.3 ENST00000403106.3 |
FGA |
fibrinogen alpha chain |
chr14_-_106963409 | 1.21 |
ENST00000390621.2 |
IGHV1-45 |
immunoglobulin heavy variable 1-45 |
chr5_-_149792295 | 1.21 |
ENST00000518797.1 ENST00000524315.1 ENST00000009530.7 ENST00000377795.3 |
CD74 |
CD74 molecule, major histocompatibility complex, class II invariant chain |
chr2_+_170590321 | 1.20 |
ENST00000392647.2 |
KLHL23 |
kelch-like family member 23 |
chr14_-_55658252 | 1.18 |
ENST00000395425.2 |
DLGAP5 |
discs, large (Drosophila) homolog-associated protein 5 |
chrX_-_70329118 | 1.17 |
ENST00000374188.3 |
IL2RG |
interleukin 2 receptor, gamma |
chr7_+_99816859 | 1.16 |
ENST00000317271.2 |
PVRIG |
poliovirus receptor related immunoglobulin domain containing |
chr22_+_23264766 | 1.16 |
ENST00000390331.2 |
IGLC7 |
immunoglobulin lambda constant 7 |
chr16_-_55867146 | 1.15 |
ENST00000422046.2 |
CES1 |
carboxylesterase 1 |
chr19_+_18284477 | 1.15 |
ENST00000407280.3 |
IFI30 |
interferon, gamma-inducible protein 30 |
chr14_-_106174960 | 1.15 |
ENST00000390547.2 |
IGHA1 |
immunoglobulin heavy constant alpha 1 |
chr7_-_71801980 | 1.15 |
ENST00000329008.5 |
CALN1 |
calneuron 1 |
chr9_-_132805430 | 1.14 |
ENST00000446176.2 ENST00000355681.3 ENST00000420781.1 |
FNBP1 |
formin binding protein 1 |
chr2_+_178257372 | 1.14 |
ENST00000264167.4 ENST00000409888.1 |
AGPS |
alkylglycerone phosphate synthase |
chr14_-_106573756 | 1.12 |
ENST00000390601.2 |
IGHV3-11 |
immunoglobulin heavy variable 3-11 (gene/pseudogene) |
chr21_-_46340884 | 1.11 |
ENST00000302347.5 ENST00000517819.1 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr2_-_61697862 | 1.10 |
ENST00000398571.2 |
USP34 |
ubiquitin specific peptidase 34 |
chr14_-_106054659 | 1.09 |
ENST00000390539.2 |
IGHA2 |
immunoglobulin heavy constant alpha 2 (A2m marker) |
chr19_-_39826639 | 1.09 |
ENST00000602185.1 ENST00000598034.1 ENST00000601387.1 ENST00000595636.1 ENST00000253054.8 ENST00000594700.1 ENST00000597595.1 |
GMFG |
glia maturation factor, gamma |
chr16_+_32077386 | 1.08 |
ENST00000354689.6 |
IGHV3OR16-9 |
immunoglobulin heavy variable 3/OR16-9 (non-functional) |
chr6_+_131894284 | 1.08 |
ENST00000368087.3 ENST00000356962.2 |
ARG1 |
arginase 1 |
chr1_-_156786634 | 1.08 |
ENST00000392306.2 ENST00000368199.3 |
SH2D2A |
SH2 domain containing 2A |
chr14_+_95047725 | 1.07 |
ENST00000554760.1 ENST00000554866.1 ENST00000329597.7 ENST00000556775.1 |
SERPINA5 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
chr12_-_63328817 | 1.06 |
ENST00000228705.6 |
PPM1H |
protein phosphatase, Mg2+/Mn2+ dependent, 1H |
chr19_-_51875894 | 1.06 |
ENST00000600427.1 ENST00000595217.1 ENST00000221978.5 |
NKG7 |
natural killer cell group 7 sequence |
chr1_-_25256368 | 1.05 |
ENST00000308873.6 |
RUNX3 |
runt-related transcription factor 3 |
chr4_-_73434498 | 1.04 |
ENST00000286657.4 |
ADAMTS3 |
ADAM metallopeptidase with thrombospondin type 1 motif, 3 |
chr12_+_102513950 | 1.04 |
ENST00000378128.3 ENST00000327680.2 ENST00000541394.1 ENST00000543784.1 |
PARPBP |
PARP1 binding protein |
chr1_+_116915855 | 1.04 |
ENST00000295598.5 |
ATP1A1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
chr8_+_81397876 | 1.03 |
ENST00000430430.1 |
ZBTB10 |
zinc finger and BTB domain containing 10 |
chr3_-_13461807 | 1.03 |
ENST00000254508.5 |
NUP210 |
nucleoporin 210kDa |
chr16_+_85645007 | 1.01 |
ENST00000405402.2 |
GSE1 |
Gse1 coiled-coil protein |
chr16_+_30212378 | 1.01 |
ENST00000569485.1 |
SULT1A3 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 |
chr17_+_76210367 | 1.01 |
ENST00000592734.1 ENST00000587746.1 |
BIRC5 |
baculoviral IAP repeat containing 5 |
chr9_+_117085336 | 0.99 |
ENST00000259396.8 ENST00000538816.1 |
ORM1 |
orosomucoid 1 |
chr18_+_32556892 | 0.99 |
ENST00000591734.1 ENST00000413393.1 ENST00000589180.1 ENST00000587359.1 |
MAPRE2 |
microtubule-associated protein, RP/EB family, member 2 |
chr2_+_33701286 | 0.99 |
ENST00000403687.3 |
RASGRP3 |
RAS guanyl releasing protein 3 (calcium and DAG-regulated) |
chr12_-_49393092 | 0.99 |
ENST00000421952.2 |
DDN |
dendrin |
chr14_-_55658323 | 0.99 |
ENST00000554067.1 ENST00000247191.2 |
DLGAP5 |
discs, large (Drosophila) homolog-associated protein 5 |
chrX_+_49363665 | 0.98 |
ENST00000381700.6 |
GAGE1 |
G antigen 1 |
chr17_+_53342311 | 0.98 |
ENST00000226067.5 |
HLF |
hepatic leukemia factor |
chrX_-_131547596 | 0.95 |
ENST00000538204.1 ENST00000370849.3 |
MBNL3 |
muscleblind-like splicing regulator 3 |
chr16_+_72088376 | 0.95 |
ENST00000570083.1 ENST00000355906.5 ENST00000398131.2 ENST00000569639.1 ENST00000564499.1 ENST00000357763.4 ENST00000562526.1 ENST00000565574.1 ENST00000568417.2 ENST00000356967.5 |
HP HPR |
haptoglobin haptoglobin-related protein |
chr1_+_39456895 | 0.94 |
ENST00000432648.3 ENST00000446189.2 ENST00000372984.4 |
AKIRIN1 |
akirin 1 |
chr3_+_121554046 | 0.93 |
ENST00000273668.2 ENST00000451944.2 |
EAF2 |
ELL associated factor 2 |
chr21_-_46340770 | 0.93 |
ENST00000397854.3 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr6_+_26158343 | 0.93 |
ENST00000377777.4 ENST00000289316.2 |
HIST1H2BD |
histone cluster 1, H2bd |
chr14_-_94856987 | 0.93 |
ENST00000449399.3 ENST00000404814.4 |
SERPINA1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr12_+_56473939 | 0.92 |
ENST00000450146.2 |
ERBB3 |
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 |
chr14_+_95047744 | 0.92 |
ENST00000553511.1 ENST00000554633.1 ENST00000555681.1 ENST00000554276.1 |
SERPINA5 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
chr10_-_23003460 | 0.92 |
ENST00000376573.4 |
PIP4K2A |
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
chr16_+_29472707 | 0.92 |
ENST00000565290.1 |
SULT1A4 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4 |
chr14_-_106733624 | 0.92 |
ENST00000390610.2 |
IGHV1-24 |
immunoglobulin heavy variable 1-24 |
chr1_-_15911510 | 0.91 |
ENST00000375826.3 |
AGMAT |
agmatine ureohydrolase (agmatinase) |
chr3_+_4535025 | 0.90 |
ENST00000302640.8 ENST00000354582.6 ENST00000423119.2 ENST00000357086.4 ENST00000456211.2 |
ITPR1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
chr17_+_56769924 | 0.90 |
ENST00000461271.1 ENST00000583539.1 ENST00000337432.4 ENST00000421782.2 |
RAD51C |
RAD51 paralog C |
chr1_+_93544821 | 0.89 |
ENST00000370303.4 |
MTF2 |
metal response element binding transcription factor 2 |
chrX_-_131547625 | 0.89 |
ENST00000394311.2 |
MBNL3 |
muscleblind-like splicing regulator 3 |
chr17_-_40428359 | 0.89 |
ENST00000293328.3 |
STAT5B |
signal transducer and activator of transcription 5B |
chr6_-_89827720 | 0.89 |
ENST00000452027.2 |
SRSF12 |
serine/arginine-rich splicing factor 12 |
chr3_-_49459878 | 0.89 |
ENST00000546031.1 ENST00000458307.2 ENST00000430521.1 |
AMT |
aminomethyltransferase |
chr1_-_247335269 | 0.89 |
ENST00000543802.2 ENST00000491356.1 ENST00000472531.1 ENST00000340684.6 |
ZNF124 |
zinc finger protein 124 |
chr16_+_3115298 | 0.88 |
ENST00000325568.5 ENST00000534507.1 |
IL32 |
interleukin 32 |
chr14_-_94856951 | 0.87 |
ENST00000553327.1 ENST00000556955.1 ENST00000557118.1 ENST00000440909.1 |
SERPINA1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr19_-_48389651 | 0.87 |
ENST00000222002.3 |
SULT2A1 |
sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 |
chr19_+_10397621 | 0.87 |
ENST00000380770.3 |
ICAM4 |
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) |
chr12_-_8025398 | 0.87 |
ENST00000535344.1 ENST00000543909.1 |
SLC2A14 |
solute carrier family 2 (facilitated glucose transporter), member 14 |
chr9_-_123676827 | 0.86 |
ENST00000546084.1 |
TRAF1 |
TNF receptor-associated factor 1 |
chr12_-_15104040 | 0.86 |
ENST00000541644.1 ENST00000545895.1 |
ARHGDIB |
Rho GDP dissociation inhibitor (GDI) beta |
chr17_+_80416482 | 0.86 |
ENST00000309794.11 ENST00000345415.7 ENST00000457415.3 ENST00000584411.1 ENST00000412079.2 ENST00000577432.1 |
NARF |
nuclear prelamin A recognition factor |
chr14_-_94857004 | 0.86 |
ENST00000557492.1 ENST00000448921.1 ENST00000437397.1 ENST00000355814.4 ENST00000393088.4 |
SERPINA1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr6_-_31620149 | 0.86 |
ENST00000435080.1 ENST00000375976.4 ENST00000441054.1 |
BAG6 |
BCL2-associated athanogene 6 |
chr1_-_156786530 | 0.85 |
ENST00000368198.3 |
SH2D2A |
SH2 domain containing 2A |
chr1_+_93544791 | 0.85 |
ENST00000545708.1 ENST00000540243.1 ENST00000370298.4 |
MTF2 |
metal response element binding transcription factor 2 |
chr17_+_25958174 | 0.85 |
ENST00000313648.6 ENST00000577392.1 ENST00000584661.1 ENST00000413914.2 |
LGALS9 |
lectin, galactoside-binding, soluble, 9 |
chrX_+_49235708 | 0.85 |
ENST00000381725.1 |
GAGE2B |
G antigen 2B |
chr19_-_10450287 | 0.85 |
ENST00000589261.1 ENST00000590569.1 ENST00000589580.1 ENST00000589249.1 |
ICAM3 |
intercellular adhesion molecule 3 |
chr17_-_5026397 | 0.85 |
ENST00000250076.3 |
ZNF232 |
zinc finger protein 232 |
chrX_+_49188094 | 0.84 |
ENST00000381751.1 |
GAGE13 |
G antigen 13 |
chr19_-_18366182 | 0.84 |
ENST00000355502.3 |
PDE4C |
phosphodiesterase 4C, cAMP-specific |
chr1_+_10271674 | 0.83 |
ENST00000377086.1 |
KIF1B |
kinesin family member 1B |
chr3_-_182880541 | 0.83 |
ENST00000470251.1 ENST00000265598.3 |
LAMP3 |
lysosomal-associated membrane protein 3 |
chr1_-_27952741 | 0.83 |
ENST00000399173.1 |
FGR |
feline Gardner-Rasheed sarcoma viral oncogene homolog |
chr12_+_6554021 | 0.83 |
ENST00000266557.3 |
CD27 |
CD27 molecule |
chr12_-_8025442 | 0.82 |
ENST00000340749.5 ENST00000535295.1 ENST00000539234.1 |
SLC2A14 |
solute carrier family 2 (facilitated glucose transporter), member 14 |
chr1_+_200993071 | 0.82 |
ENST00000446333.1 ENST00000458003.1 |
RP11-168O16.1 |
RP11-168O16.1 |
chr1_-_169680745 | 0.82 |
ENST00000236147.4 |
SELL |
selectin L |
chr19_-_39108568 | 0.81 |
ENST00000586296.1 |
MAP4K1 |
mitogen-activated protein kinase kinase kinase kinase 1 |
chr17_+_67498538 | 0.80 |
ENST00000589647.1 |
MAP2K6 |
mitogen-activated protein kinase kinase 6 |
chr2_+_201994042 | 0.80 |
ENST00000417748.1 |
CFLAR |
CASP8 and FADD-like apoptosis regulator |
chr5_-_34043310 | 0.80 |
ENST00000231338.7 |
C1QTNF3 |
C1q and tumor necrosis factor related protein 3 |
chr16_+_28943260 | 0.80 |
ENST00000538922.1 ENST00000324662.3 ENST00000567541.1 |
CD19 |
CD19 molecule |
chr4_+_15779901 | 0.79 |
ENST00000226279.3 |
CD38 |
CD38 molecule |
chr17_-_76836963 | 0.79 |
ENST00000312010.6 |
USP36 |
ubiquitin specific peptidase 36 |
chr3_-_49459865 | 0.79 |
ENST00000427987.1 |
AMT |
aminomethyltransferase |
chr11_+_121322832 | 0.79 |
ENST00000260197.7 |
SORL1 |
sortilin-related receptor, L(DLR class) A repeats containing |
chr18_+_29671812 | 0.79 |
ENST00000261593.3 ENST00000578914.1 |
RNF138 |
ring finger protein 138, E3 ubiquitin protein ligase |
chr1_+_16090914 | 0.79 |
ENST00000441801.2 |
FBLIM1 |
filamin binding LIM protein 1 |
chrX_-_131623982 | 0.79 |
ENST00000370844.1 |
MBNL3 |
muscleblind-like splicing regulator 3 |
chr17_-_29648761 | 0.78 |
ENST00000247270.3 ENST00000462804.2 |
EVI2A |
ecotropic viral integration site 2A |
chr19_-_48673580 | 0.78 |
ENST00000427526.2 |
LIG1 |
ligase I, DNA, ATP-dependent |
chr17_-_34524157 | 0.78 |
ENST00000378354.4 ENST00000394484.1 |
CCL3L3 |
chemokine (C-C motif) ligand 3-like 3 |
chr11_-_28129656 | 0.78 |
ENST00000263181.6 |
KIF18A |
kinesin family member 18A |
chr14_-_106692191 | 0.77 |
ENST00000390607.2 |
IGHV3-21 |
immunoglobulin heavy variable 3-21 |
chr22_-_41215328 | 0.77 |
ENST00000434185.1 ENST00000435456.2 |
SLC25A17 |
solute carrier family 25 (mitochondrial carrier; peroxisomal membrane protein, 34kDa), member 17 |
chr17_-_34625719 | 0.76 |
ENST00000422211.2 ENST00000542124.1 |
CCL3L1 |
chemokine (C-C motif) ligand 3-like 1 |
chr1_+_179923873 | 0.76 |
ENST00000367607.3 ENST00000491495.2 |
CEP350 |
centrosomal protein 350kDa |
chr11_-_86666427 | 0.76 |
ENST00000531380.1 |
FZD4 |
frizzled family receptor 4 |
chr18_+_268148 | 0.76 |
ENST00000581677.1 |
RP11-705O1.8 |
RP11-705O1.8 |
chr17_+_4675175 | 0.76 |
ENST00000270560.3 |
TM4SF5 |
transmembrane 4 L six family member 5 |
chr20_+_30639991 | 0.76 |
ENST00000534862.1 ENST00000538448.1 ENST00000375862.2 |
HCK |
hemopoietic cell kinase |
chr8_-_124408652 | 0.76 |
ENST00000287394.5 |
ATAD2 |
ATPase family, AAA domain containing 2 |
chr1_+_209929377 | 0.76 |
ENST00000400959.3 ENST00000367025.3 |
TRAF3IP3 |
TRAF3 interacting protein 3 |
chr4_-_39367949 | 0.76 |
ENST00000503784.1 ENST00000349703.2 ENST00000381897.1 |
RFC1 |
replication factor C (activator 1) 1, 145kDa |
chr2_+_68592305 | 0.76 |
ENST00000234313.7 |
PLEK |
pleckstrin |
chr5_+_176513868 | 0.76 |
ENST00000292408.4 |
FGFR4 |
fibroblast growth factor receptor 4 |
chr12_+_54892550 | 0.75 |
ENST00000545638.2 |
NCKAP1L |
NCK-associated protein 1-like |
chr7_+_73623717 | 0.75 |
ENST00000344995.5 ENST00000460943.1 |
LAT2 |
linker for activation of T cells family, member 2 |
chr8_+_11534462 | 0.75 |
ENST00000528712.1 ENST00000532977.1 |
GATA4 |
GATA binding protein 4 |
chr14_-_21516590 | 0.75 |
ENST00000555026.1 |
NDRG2 |
NDRG family member 2 |
chr1_+_32716840 | 0.75 |
ENST00000336890.5 |
LCK |
lymphocyte-specific protein tyrosine kinase |
chr13_+_50656307 | 0.75 |
ENST00000378180.4 |
DLEU1 |
deleted in lymphocytic leukemia 1 (non-protein coding) |
chr1_+_244998602 | 0.75 |
ENST00000411948.2 |
COX20 |
COX20 cytochrome C oxidase assembly factor |
chr19_-_55866061 | 0.74 |
ENST00000588572.2 ENST00000593184.1 ENST00000589467.1 |
COX6B2 |
cytochrome c oxidase subunit VIb polypeptide 2 (testis) |
chr12_-_8025623 | 0.74 |
ENST00000542782.1 ENST00000396589.2 ENST00000535266.1 ENST00000542505.1 |
SLC2A14 |
solute carrier family 2 (facilitated glucose transporter), member 14 |
chr22_-_29138386 | 0.74 |
ENST00000544772.1 |
CHEK2 |
checkpoint kinase 2 |
chr2_+_11696464 | 0.74 |
ENST00000234142.5 |
GREB1 |
growth regulation by estrogen in breast cancer 1 |
chr2_+_61108650 | 0.73 |
ENST00000295025.8 |
REL |
v-rel avian reticuloendotheliosis viral oncogene homolog |
chr16_+_12995468 | 0.73 |
ENST00000424107.3 ENST00000558583.1 ENST00000558318.1 |
SHISA9 |
shisa family member 9 |
chr20_+_35201993 | 0.73 |
ENST00000373872.4 |
TGIF2 |
TGFB-induced factor homeobox 2 |
chr7_-_99569468 | 0.73 |
ENST00000419575.1 |
AZGP1 |
alpha-2-glycoprotein 1, zinc-binding |
chr20_+_35201857 | 0.73 |
ENST00000373874.2 |
TGIF2 |
TGFB-induced factor homeobox 2 |
chr3_-_47823298 | 0.72 |
ENST00000254480.5 |
SMARCC1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
chr14_-_94789663 | 0.72 |
ENST00000557225.1 ENST00000341584.3 |
SERPINA6 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 |
chr2_-_40679186 | 0.72 |
ENST00000406785.2 |
SLC8A1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
chr2_+_11674213 | 0.71 |
ENST00000381486.2 |
GREB1 |
growth regulation by estrogen in breast cancer 1 |
chr22_+_40322595 | 0.71 |
ENST00000420971.1 ENST00000544756.1 |
GRAP2 |
GRB2-related adaptor protein 2 |
chr7_+_64126535 | 0.71 |
ENST00000344930.3 |
ZNF107 |
zinc finger protein 107 |
chr17_+_18380051 | 0.70 |
ENST00000581545.1 ENST00000582333.1 ENST00000328114.6 ENST00000412421.2 ENST00000583322.1 ENST00000584941.1 |
LGALS9C |
lectin, galactoside-binding, soluble, 9C |
chr22_+_40322623 | 0.70 |
ENST00000399090.2 |
GRAP2 |
GRB2-related adaptor protein 2 |
chr2_+_201994208 | 0.70 |
ENST00000440180.1 |
CFLAR |
CASP8 and FADD-like apoptosis regulator |
chr13_+_50202435 | 0.70 |
ENST00000282026.1 |
ARL11 |
ADP-ribosylation factor-like 11 |
chr8_+_6565854 | 0.70 |
ENST00000285518.6 |
AGPAT5 |
1-acylglycerol-3-phosphate O-acyltransferase 5 |
chr1_+_207627697 | 0.70 |
ENST00000458541.2 |
CR2 |
complement component (3d/Epstein Barr virus) receptor 2 |
chr6_+_64345698 | 0.70 |
ENST00000506783.1 ENST00000481385.2 ENST00000515594.1 ENST00000494284.2 ENST00000262043.3 |
PHF3 |
PHD finger protein 3 |
chr19_-_48752812 | 0.69 |
ENST00000359009.4 |
CARD8 |
caspase recruitment domain family, member 8 |
chr5_-_176433350 | 0.69 |
ENST00000377227.4 ENST00000377219.2 |
UIMC1 |
ubiquitin interaction motif containing 1 |
chr3_-_120365866 | 0.69 |
ENST00000475447.2 |
HGD |
homogentisate 1,2-dioxygenase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 3.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 4.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 2.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 4.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 3.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 2.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 2.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 2.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 1.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 2.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 6.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 2.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 2.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 1.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 1.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 3.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.6 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.8 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
1.3 | 3.8 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
1.2 | 3.7 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
0.9 | 3.5 | GO:0061289 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.8 | 3.3 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.7 | 2.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.7 | 5.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.7 | 3.4 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.6 | 1.9 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.6 | 1.8 | GO:0060621 | regulation of cholesterol import(GO:0060620) negative regulation of cholesterol import(GO:0060621) regulation of sterol import(GO:2000909) negative regulation of sterol import(GO:2000910) |
0.6 | 3.6 | GO:0030421 | defecation(GO:0030421) |
0.6 | 1.7 | GO:0061010 | negative regulation of transcription by transcription factor localization(GO:0010621) gall bladder development(GO:0061010) |
0.5 | 2.1 | GO:0014028 | notochord formation(GO:0014028) |
0.5 | 2.3 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.4 | 2.1 | GO:1902896 | terminal web assembly(GO:1902896) |
0.4 | 1.5 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
0.4 | 1.4 | GO:1904327 | maintenance of unfolded protein(GO:0036506) protein localization to cytosolic proteasome complex(GO:1904327) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.3 | 1.4 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
0.3 | 2.0 | GO:0061517 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.3 | 1.0 | GO:1900138 | negative regulation of phospholipase A2 activity(GO:1900138) |
0.3 | 0.9 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
0.3 | 0.9 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.3 | 3.0 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.3 | 0.8 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.3 | 1.0 | GO:1903288 | protein transport into plasma membrane raft(GO:0044861) positive regulation of potassium ion import(GO:1903288) |
0.2 | 0.7 | GO:0010652 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
0.2 | 2.0 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.2 | 1.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.2 | 4.8 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 0.9 | GO:0099542 | retrograde trans-synaptic signaling(GO:0098917) trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) |
0.2 | 0.5 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.2 | 1.1 | GO:0032571 | response to vitamin K(GO:0032571) |
0.2 | 0.6 | GO:2000777 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) positive regulation of oocyte maturation(GO:1900195) negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.2 | 2.3 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.2 | 0.6 | GO:1904479 | cellular response to bile acid(GO:1903413) negative regulation of intestinal absorption(GO:1904479) response to iron ion starvation(GO:1990641) |
0.2 | 2.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 1.5 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.2 | 0.3 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.2 | 0.5 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
0.2 | 1.5 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.1 | 0.7 | GO:0044855 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.1 | 1.9 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 3.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.4 | GO:0006788 | heme oxidation(GO:0006788) smooth muscle hyperplasia(GO:0014806) |
0.1 | 0.7 | GO:0003070 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.4 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
0.1 | 0.8 | GO:0035803 | egg coat formation(GO:0035803) |
0.1 | 0.4 | GO:1903570 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
0.1 | 0.4 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 2.7 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 0.7 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.6 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.5 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.1 | 2.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 1.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.8 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
0.1 | 0.3 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
0.1 | 0.5 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.3 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.1 | 0.1 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.1 | 0.2 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.1 | 0.6 | GO:0021730 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.1 | 0.2 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
0.1 | 1.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.3 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.1 | 0.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 1.8 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 1.3 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.8 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.6 | GO:0051414 | response to cortisol(GO:0051414) |
0.1 | 0.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.1 | 0.3 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.1 | 0.3 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.1 | 1.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 2.6 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.2 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.1 | 0.8 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 3.7 | GO:0021545 | cranial nerve development(GO:0021545) |
0.1 | 0.8 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.1 | 0.3 | GO:0051582 | peptidyl-cysteine methylation(GO:0018125) positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.1 | 0.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.2 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 2.0 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.9 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 1.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 0.3 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.0 | 0.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.1 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.0 | 0.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.7 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.1 | GO:0008050 | female courtship behavior(GO:0008050) positive regulation of female receptivity(GO:0045925) |
0.0 | 0.2 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.0 | 0.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.0 | 0.1 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
0.0 | 0.4 | GO:0002911 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.0 | 0.3 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.0 | 1.6 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.1 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.0 | 1.0 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.0 | 0.3 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 2.1 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 2.6 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.5 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.0 | 1.3 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 1.4 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.9 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.2 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.0 | 0.2 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 0.1 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.0 | 0.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.1 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.0 | 0.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.0 | 0.6 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.1 | GO:0060969 | negative regulation of gene silencing(GO:0060969) |
0.0 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.3 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.2 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 0.1 | GO:0060579 | ventral spinal cord interneuron specification(GO:0021521) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) cell fate specification involved in pattern specification(GO:0060573) ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.0 | 0.1 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.0 | 0.4 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.1 | GO:0039003 | pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) thyroid-stimulating hormone secretion(GO:0070460) kidney rudiment formation(GO:0072003) kidney field specification(GO:0072004) metanephric nephron tubule formation(GO:0072289) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.0 | 0.8 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.0 | 0.4 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.2 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.5 | GO:0032967 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.0 | 0.2 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.0 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.0 | GO:0002384 | hepatic immune response(GO:0002384) |
0.0 | 0.1 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
0.0 | 0.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 0.3 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.9 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 1.0 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.3 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.2 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.0 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.0 | 0.1 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
0.0 | 0.1 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.6 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.1 | GO:0043383 | negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
0.0 | 0.0 | GO:0046136 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.0 | 0.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.2 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.0 | 0.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 0.0 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.8 | GO:0046136 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.3 | 1.3 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.3 | 1.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.2 | 2.2 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.2 | 1.0 | GO:0097527 | Fas signaling pathway(GO:0036337) necroptotic signaling pathway(GO:0097527) |
0.1 | 1.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.9 | GO:0035803 | egg coat formation(GO:0035803) |
0.1 | 0.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.1 | 0.9 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.3 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 0.5 | GO:0051414 | response to cortisol(GO:0051414) |
0.1 | 0.7 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.1 | 1.8 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.1 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.0 | 0.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.1 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
0.0 | 0.2 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.1 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.0 | 0.1 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
0.0 | 0.1 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.0 | 0.2 | GO:0009441 | glycolate metabolic process(GO:0009441) |
0.0 | 0.2 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
0.0 | 0.1 | GO:1905068 | arterial endothelial cell fate commitment(GO:0060844) blood vessel lumenization(GO:0072554) positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.0 | 0.1 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
0.0 | 0.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.7 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.0 | 0.1 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.0 | 0.3 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.0 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.1 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.7 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.8 | 3.4 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.8 | 3.3 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.8 | 3.9 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.6 | 5.1 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.5 | 1.5 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.5 | 2.5 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
0.4 | 1.8 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.4 | 1.8 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.4 | 1.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.4 | 2.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.3 | 0.6 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.2 | 0.7 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
0.2 | 0.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 3.0 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 3.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 4.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 3.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 1.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 1.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 0.5 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.2 | 0.9 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.1 | 0.7 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
0.1 | 0.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 1.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.4 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.1 | 1.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 1.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 1.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 0.3 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
0.1 | 0.6 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 5.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.6 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.1 | 1.9 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.8 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.3 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.1 | 0.8 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.4 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.7 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.3 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.1 | 1.3 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 1.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.6 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 1.0 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.4 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.1 | 1.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.7 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 1.7 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 5.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.8 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.6 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.0 | 1.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.2 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.0 | 0.1 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.7 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 1.3 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 0.3 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 0.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 1.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 4.9 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.1 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.0 | 0.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 1.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 2.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 2.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.0 | 0.1 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
0.0 | 1.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.7 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.2 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.1 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.0 | 0.2 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.7 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.4 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.9 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.9 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.8 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 1.1 | GO:0016209 | antioxidant activity(GO:0016209) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.9 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.0 | 0.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 1.6 | GO:0020037 | heme binding(GO:0020037) |
0.0 | 0.0 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.0 | 0.1 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.0 | 0.6 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.0 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.0 | 0.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 1.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 1.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.7 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 2.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 2.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 2.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 2.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 5.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 4.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 1.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 3.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 2.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 2.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 2.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 2.0 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 4.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 1.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.9 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 1.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 1.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 1.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 2.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 4.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.1 | PID MYC PATHWAY | C-MYC pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 10.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 3.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 3.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 5.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 2.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.9 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 3.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 4.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 4.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 1.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 3.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 1.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 3.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 3.2 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 3.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 2.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 1.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 1.0 | PID ATM PATHWAY | ATM pathway |
0.0 | 2.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 1.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 1.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.4 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 1.5 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 1.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.3 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 1.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.9 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 2.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 1.1 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.3 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.5 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.7 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.1 | 1.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 0.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.3 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.1 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.0 | 1.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 1.8 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.4 | 5.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.4 | 1.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 3.8 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.2 | 2.6 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 0.5 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 1.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) extrinsic component of endosome membrane(GO:0031313) |
0.2 | 5.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 1.0 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 0.9 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.1 | 0.9 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.8 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 1.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 2.0 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 1.7 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 1.1 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.1 | 1.3 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.5 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.1 | 1.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.6 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 2.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.5 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 7.6 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 0.3 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.5 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.1 | 0.6 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 1.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 0.7 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.0 | 0.3 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.0 | 0.2 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.2 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.0 | 0.2 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.0 | 0.2 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
0.0 | 0.6 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.0 | 0.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 1.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.3 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 1.7 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 7.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 2.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.6 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 1.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.1 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.0 | 0.1 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
0.0 | 0.3 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 3.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 1.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.0 | 0.8 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 2.4 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.3 | GO:0005839 | proteasome core complex(GO:0005839) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 1.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 1.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 4.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.7 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.9 | 4.4 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.8 | 2.4 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
0.7 | 2.1 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
0.7 | 2.0 | GO:0061010 | negative regulation of transcription by transcription factor localization(GO:0010621) gall bladder development(GO:0061010) |
0.6 | 3.1 | GO:1902896 | terminal web assembly(GO:1902896) |
0.6 | 1.8 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.6 | 3.0 | GO:0001315 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.6 | 2.4 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.6 | 2.3 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.5 | 1.6 | GO:1902303 | regulation of heart rate by hormone(GO:0003064) negative regulation of potassium ion export(GO:1902303) |
0.5 | 1.6 | GO:0060621 | regulation of cholesterol import(GO:0060620) negative regulation of cholesterol import(GO:0060621) regulation of sterol import(GO:2000909) negative regulation of sterol import(GO:2000910) |
0.5 | 1.4 | GO:2000525 | dendritic cell dendrite assembly(GO:0097026) regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) regulation of dendritic cell dendrite assembly(GO:2000547) |
0.4 | 1.8 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.4 | 1.3 | GO:0043132 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) NAD transport(GO:0043132) |
0.4 | 1.3 | GO:1902994 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
0.4 | 2.0 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.4 | 2.0 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.4 | 1.1 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.4 | 1.5 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.4 | 2.2 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
0.4 | 1.1 | GO:1902023 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.3 | 1.4 | GO:0014028 | notochord formation(GO:0014028) |
0.3 | 1.7 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.3 | 1.6 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.3 | 1.3 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.3 | 0.9 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.3 | 3.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.3 | 1.5 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.3 | 2.1 | GO:1904925 | negative regulation of mitochondrial membrane permeability(GO:0035795) positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.3 | 0.6 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.3 | 1.5 | GO:0032571 | response to vitamin K(GO:0032571) |
0.3 | 1.7 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.3 | 1.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.3 | 0.8 | GO:1904647 | response to rotenone(GO:1904647) |
0.3 | 0.8 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.3 | 1.3 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.3 | 0.8 | GO:1902771 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
0.3 | 1.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.3 | 1.3 | GO:1903412 | response to bile acid(GO:1903412) |
0.3 | 1.0 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
0.3 | 2.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.3 | 0.8 | GO:0003285 | septum secundum development(GO:0003285) |
0.2 | 0.7 | GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.2 | 1.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 0.7 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
0.2 | 0.9 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) |
0.2 | 2.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.2 | 0.7 | GO:1901355 | response to rapamycin(GO:1901355) |
0.2 | 1.1 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.2 | 0.7 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.2 | 0.9 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.2 | 0.9 | GO:1904379 | maintenance of unfolded protein(GO:0036506) protein localization to cytosolic proteasome complex(GO:1904327) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.2 | 2.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 0.6 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.2 | 1.2 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.2 | 1.0 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.2 | 4.8 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.2 | 0.8 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.2 | 0.6 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.2 | 0.6 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.2 | 0.6 | GO:1903939 | negative regulation of histone H3-K9 dimethylation(GO:1900110) regulation of TORC2 signaling(GO:1903939) |
0.2 | 0.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 1.0 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 0.2 | GO:0036115 | fatty-acyl-CoA catabolic process(GO:0036115) |
0.2 | 0.4 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.2 | 0.5 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
0.2 | 0.9 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
0.2 | 1.3 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.2 | 0.5 | GO:0045082 | interleukin-4 biosynthetic process(GO:0042097) positive regulation of interleukin-10 biosynthetic process(GO:0045082) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.2 | 0.5 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.2 | 1.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 1.0 | GO:1903416 | response to glycoside(GO:1903416) |
0.2 | 0.7 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.2 | 0.5 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
0.2 | 0.3 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.2 | 0.5 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
0.2 | 0.5 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.2 | 1.2 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.2 | 1.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 0.5 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.2 | 0.5 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
0.2 | 0.6 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.2 | 0.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 0.5 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.2 | 4.2 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.2 | 1.5 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.1 | 0.6 | GO:0022614 | membrane to membrane docking(GO:0022614) establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 0.3 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.1 | 2.4 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 2.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.4 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.1 | 0.4 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.1 | 0.6 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.1 | 1.0 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.1 | 1.0 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.1 | 0.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 0.4 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
0.1 | 1.1 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 2.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 2.7 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.3 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
0.1 | 0.3 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 2.2 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.1 | 3.0 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.4 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.1 | 0.9 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.4 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.1 | 2.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 2.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 1.0 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.4 | GO:0097254 | renal tubular secretion(GO:0097254) |
0.1 | 0.6 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 0.4 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 3.1 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.1 | 0.2 | GO:0019827 | stem cell population maintenance(GO:0019827) maintenance of cell number(GO:0098727) |
0.1 | 0.4 | GO:0032292 | Schwann cell development(GO:0014044) myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.1 | 0.1 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.1 | 0.4 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.1 | 0.4 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.1 | 0.4 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.1 | 0.3 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.7 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.8 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.1 | 0.5 | GO:0051958 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
0.1 | 2.4 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.5 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.1 | 0.3 | GO:1990519 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
0.1 | 0.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.4 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 2.6 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.5 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 7.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 1.1 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.1 | 1.5 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.3 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.6 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.9 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.5 | GO:0036100 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.1 | 0.3 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.6 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.1 | 0.2 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.2 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.5 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.6 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.1 | 0.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.4 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 0.6 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.1 | 0.2 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.1 | 0.7 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.4 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.1 | 0.1 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.1 | 0.7 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.8 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.1 | 0.6 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 1.0 | GO:0007422 | peripheral nervous system development(GO:0007422) |
0.1 | 0.3 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
0.1 | 0.2 | GO:0090135 | actin filament branching(GO:0090135) |
0.1 | 0.9 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 0.3 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.1 | 0.8 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 0.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 0.3 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.1 | 0.3 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
0.1 | 1.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.5 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.1 | 0.6 | GO:0071315 | cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
0.1 | 0.3 | GO:1904303 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) positive regulation of leukocyte tethering or rolling(GO:1903238) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.1 | 1.1 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.1 | 5.5 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.1 | 0.3 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
0.1 | 0.3 | GO:0010585 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.1 | 1.6 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.3 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.1 | 0.3 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.1 | 1.4 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.3 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.1 | 1.3 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
0.1 | 0.3 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.1 | 0.2 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.1 | 0.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.3 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 0.2 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.5 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.1 | 0.7 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.4 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.1 | 0.6 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 1.3 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 0.2 | GO:0051899 | membrane depolarization(GO:0051899) |
0.1 | 0.3 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.4 | GO:0048599 | oocyte development(GO:0048599) |
0.1 | 0.7 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.1 | 0.9 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 1.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.1 | 0.2 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.1 | 1.0 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.6 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.5 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 1.6 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.1 | 0.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.9 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.1 | 4.1 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 1.4 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 1.5 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 1.0 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 3.0 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.1 | 0.3 | GO:0035711 | plasmacytoid dendritic cell activation(GO:0002270) T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) regulation of restriction endodeoxyribonuclease activity(GO:0032072) T-helper 1 cell activation(GO:0035711) negative regulation of apoptotic cell clearance(GO:2000426) regulation of nucleotide-excision repair(GO:2000819) |
0.1 | 0.3 | GO:0050711 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 secretion(GO:0050711) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.1 | 0.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.5 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.1 | 0.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.4 | GO:1905031 | regulation of potassium ion export(GO:1902302) regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) regulation of potassium ion export across plasma membrane(GO:1903764) regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905024) regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905031) |
0.1 | 0.5 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.8 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
0.1 | 0.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.4 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.5 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.1 | GO:1990637 | response to prolactin(GO:1990637) |
0.1 | 0.4 | GO:1990774 | tumor necrosis factor secretion(GO:1990774) |
0.1 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 1.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.9 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.1 | 0.2 | GO:1990502 | dense core granule maturation(GO:1990502) |
0.1 | 0.2 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 0.2 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 0.4 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 0.4 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.1 | 0.4 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 0.6 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.2 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.1 | 0.3 | GO:0048852 | hypophysis morphogenesis(GO:0048850) diencephalon morphogenesis(GO:0048852) |
0.1 | 1.0 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.3 | GO:1902775 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.5 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.8 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.1 | 0.3 | GO:0009149 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
0.1 | 1.2 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.6 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.1 | 0.5 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.2 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 1.2 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 0.2 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.4 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.1 | 0.5 | GO:0006999 | nuclear pore organization(GO:0006999) nuclear pore complex assembly(GO:0051292) |
0.1 | 0.9 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 0.2 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.1 | 0.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.6 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 0.2 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.1 | 0.4 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.5 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.4 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 0.9 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 1.3 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.2 | GO:0008300 | isoprenoid catabolic process(GO:0008300) diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.5 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.3 | GO:0050951 | detection of temperature stimulus(GO:0016048) sensory perception of temperature stimulus(GO:0050951) |
0.0 | 0.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.0 | 0.3 | GO:0030033 | microvillus assembly(GO:0030033) |
0.0 | 0.4 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.0 | 0.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.0 | 0.1 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
0.0 | 0.5 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.9 | GO:0006584 | catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
0.0 | 1.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.6 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.1 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.0 | 0.1 | GO:0060844 | arterial endothelial cell fate commitment(GO:0060844) blood vessel lumenization(GO:0072554) positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.0 | 0.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.2 | GO:0051167 | xylulose metabolic process(GO:0005997) glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
0.0 | 0.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.2 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.0 | 0.6 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.2 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 1.8 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.0 | 0.6 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.0 | 0.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.4 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.3 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.0 | 0.5 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.3 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 1.0 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.7 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.0 | 0.2 | GO:0006574 | valine catabolic process(GO:0006574) |
0.0 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.0 | 0.3 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.0 | 0.2 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.0 | 0.3 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 1.1 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.5 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.0 | 0.2 | GO:0090278 | negative regulation of insulin secretion(GO:0046676) negative regulation of peptide hormone secretion(GO:0090278) |
0.0 | 1.6 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 0.1 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
0.0 | 0.6 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.0 | 0.2 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.0 | 0.4 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.2 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.0 | 1.2 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.0 | 0.9 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.0 | 0.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.3 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.0 | 0.1 | GO:0044268 | angiotensin catabolic process in blood(GO:0002005) multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) multicellular organismal protein metabolic process(GO:0044268) |
0.0 | 0.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.6 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.0 | 0.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.0 | 0.2 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.1 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.0 | 0.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.3 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.0 | 0.6 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.6 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.0 | 0.2 | GO:0046520 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.4 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.1 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.0 | 0.1 | GO:0002188 | formation of cytoplasmic translation initiation complex(GO:0001732) translation reinitiation(GO:0002188) |
0.0 | 0.2 | GO:0015692 | lead ion transport(GO:0015692) |
0.0 | 0.9 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.2 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.2 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.2 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.0 | 0.3 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.2 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.2 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.9 | GO:0006582 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.0 | 0.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.3 | GO:0006228 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
0.0 | 0.3 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.0 | 0.1 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.0 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.7 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.2 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.0 | 0.1 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.4 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.0 | 0.1 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.0 | 0.3 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.2 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.1 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.8 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.2 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.0 | 0.4 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.0 | 0.1 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.0 | 0.4 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 0.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.0 | 0.7 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 0.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.3 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.1 | GO:0050893 | sensory processing(GO:0050893) |
0.0 | 0.0 | GO:0070243 | regulation of thymocyte apoptotic process(GO:0070243) |
0.0 | 0.7 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.4 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.0 | 1.0 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.0 | 0.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 2.3 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 1.7 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.1 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.7 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.0 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.6 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.0 | 0.3 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.5 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.0 | 1.3 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.4 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.2 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.0 | 0.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.2 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.0 | 0.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.2 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.1 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.0 | 0.1 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.0 | 0.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.1 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.0 | 0.5 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.0 | 0.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.2 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.5 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.8 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.0 | 0.0 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.0 | 1.8 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.0 | 0.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.1 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.9 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.4 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.2 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.3 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.1 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.1 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.1 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.0 | 0.1 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.0 | 0.3 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) adaptation of signaling pathway(GO:0023058) |
0.0 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.1 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
0.0 | 0.3 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.2 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.0 | 0.1 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.0 | 0.2 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.2 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 0.1 | GO:0044070 | regulation of anion transport(GO:0044070) |
0.0 | 1.6 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.7 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.0 | 1.6 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.1 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.0 | 0.1 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.0 | 0.3 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.4 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 0.4 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.2 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.4 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.0 | 0.2 | GO:0097369 | sodium ion import(GO:0097369) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.0 | 1.1 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.1 | GO:1902416 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
0.0 | 0.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.2 | GO:0051321 | meiotic cell cycle(GO:0051321) |
0.0 | 0.2 | GO:0071353 | response to interleukin-4(GO:0070670) cellular response to interleukin-4(GO:0071353) |
0.0 | 0.2 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
0.0 | 0.6 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.6 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.1 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) |
0.0 | 0.3 | GO:0016236 | macroautophagy(GO:0016236) |
0.0 | 0.2 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.7 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.5 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.1 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.1 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.0 | 0.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.1 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.0 | 0.1 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.0 | 0.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.5 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.5 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 0.2 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.0 | 0.1 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.0 | 1.0 | GO:0070126 | mitochondrial translational elongation(GO:0070125) mitochondrial translational termination(GO:0070126) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.2 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.0 | 0.1 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.0 | 0.6 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.0 | 0.3 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.0 | 0.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 1.0 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.4 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.3 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.2 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.6 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.1 | GO:0045143 | homologous chromosome segregation(GO:0045143) |
0.0 | 1.5 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
0.0 | 0.7 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.0 | 0.0 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.2 | GO:0009948 | anterior/posterior axis specification(GO:0009948) |
0.0 | 0.0 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.0 | 0.5 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.3 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 0.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.4 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.0 | 0.3 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.0 | 0.1 | GO:0051591 | response to cAMP(GO:0051591) |
0.0 | 0.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.1 | GO:0072503 | cellular divalent inorganic cation homeostasis(GO:0072503) divalent inorganic cation homeostasis(GO:0072507) |
0.0 | 0.0 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.0 | 0.0 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.0 | 0.1 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.0 | 0.1 | GO:0015732 | prostaglandin transport(GO:0015732) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.0 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 0.4 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.1 | 0.3 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) thymidine kinase activity(GO:0004797) |
0.1 | 1.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.9 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 2.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.0 | 5.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.2 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.0 | 0.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.8 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.2 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.1 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.0 | 0.1 | GO:0045174 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.0 | 0.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.2 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.0 | 1.1 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.4 | GO:0071745 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
0.7 | 2.0 | GO:0097182 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
0.6 | 2.3 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.5 | 1.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.5 | 2.6 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.5 | 3.8 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.4 | 1.3 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.4 | 1.8 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.3 | 1.7 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.3 | 2.3 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 4.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 0.9 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.2 | 0.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 1.7 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 0.9 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 0.6 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.2 | 1.1 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 2.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 1.2 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.2 | 0.7 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 8.0 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.2 | 2.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.6 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 0.3 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.1 | 0.5 | GO:0000811 | GINS complex(GO:0000811) |
0.1 | 0.8 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.9 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.9 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.4 | GO:0097447 | dendritic tree(GO:0097447) |
0.1 | 2.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 1.9 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 1.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 2.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 0.7 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 1.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.4 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 1.3 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.8 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 2.1 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 3.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 1.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.5 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.7 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.6 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.7 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 2.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.8 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.4 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.7 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 0.4 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 1.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 1.8 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 1.2 | GO:0001741 | XY body(GO:0001741) |
0.1 | 1.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.4 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 0.5 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.3 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.1 | 0.6 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 8.1 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 0.4 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.3 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 1.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.7 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.9 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.6 | GO:0016013 | syntrophin complex(GO:0016013) |
0.1 | 0.7 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.6 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.5 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.7 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 0.3 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.1 | 0.6 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 1.8 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.4 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.1 | 0.4 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.4 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 1.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.4 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 0.2 | GO:0031213 | RSF complex(GO:0031213) |
0.1 | 0.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.5 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 2.5 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.2 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.0 | 0.5 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 1.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.2 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 1.2 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.7 | GO:0097227 | sperm annulus(GO:0097227) |
0.0 | 0.2 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.0 | 0.1 | GO:0000793 | condensed chromosome(GO:0000793) |
0.0 | 1.2 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.6 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.8 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 1.0 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 2.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.8 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.0 | 1.4 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 2.2 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.3 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 1.4 | GO:0044815 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.0 | 0.6 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 3.3 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 2.1 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.2 | GO:0070826 | paraferritin complex(GO:0070826) |
0.0 | 0.6 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.0 | 0.3 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.0 | 0.3 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.5 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.5 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.4 | GO:0044754 | autolysosome(GO:0044754) |
0.0 | 5.8 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.1 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.0 | 0.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.1 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.0 | 0.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 1.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.0 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
0.0 | 4.1 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 0.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 0.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 1.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 3.2 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 1.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.7 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.1 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 0.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.1 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.0 | 1.2 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.3 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.2 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.3 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 0.4 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.1 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 7.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 1.4 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.1 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.5 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.5 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.0 | 0.0 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.1 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.0 | 0.5 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.2 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 0.3 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 1.3 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.4 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.6 | 3.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.6 | 2.4 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.6 | 2.8 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
0.5 | 4.0 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.4 | 1.3 | GO:0051185 | FAD transmembrane transporter activity(GO:0015230) coenzyme transporter activity(GO:0051185) |
0.4 | 1.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.4 | 1.7 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.4 | 1.6 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.4 | 1.2 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
0.4 | 1.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.4 | 1.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 3.0 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 0.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 2.0 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.3 | 3.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.3 | 2.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 0.8 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
0.2 | 4.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 1.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 0.7 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.2 | 1.4 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.2 | 1.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 4.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 0.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 0.6 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.2 | 0.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 1.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 0.6 | GO:0047086 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
0.2 | 0.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 10.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 1.6 | GO:0008865 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.2 | 2.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.2 | 0.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 1.5 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 0.5 | GO:0052870 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
0.2 | 1.0 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.2 | 0.5 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.2 | 0.8 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 1.1 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.2 | 0.5 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.2 | 0.6 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
0.2 | 0.9 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.2 | 0.5 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 2.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 1.7 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.6 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.1 | 0.5 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 0.9 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 1.1 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.1 | 0.5 | GO:0047718 | indanol dehydrogenase activity(GO:0047718) |
0.1 | 0.5 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.1 | 2.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.4 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
0.1 | 0.9 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.9 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.9 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.4 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.1 | 0.5 | GO:0032810 | sterol response element binding(GO:0032810) |
0.1 | 0.4 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.1 | 0.4 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.1 | 0.5 | GO:0008518 | reduced folate carrier activity(GO:0008518) methotrexate transporter activity(GO:0015350) |
0.1 | 0.3 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
0.1 | 0.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 0.9 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.8 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.3 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
0.1 | 0.3 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.1 | 2.0 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.1 | 0.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 1.0 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.1 | 2.5 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.3 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.3 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.1 | 0.5 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 0.6 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.1 | 0.4 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
0.1 | 0.3 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.1 | 2.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 1.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.3 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
0.1 | 0.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.1 | GO:0001855 | complement component C4b binding(GO:0001855) |
0.1 | 0.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.6 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.6 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.1 | 0.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.3 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.1 | 2.1 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.1 | 0.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.5 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 1.6 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.9 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 2.0 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 0.6 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.1 | 0.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.2 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
0.1 | 1.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.3 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.1 | 0.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.6 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.4 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 0.3 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.5 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.8 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.6 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 2.8 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 4.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 1.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.3 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.1 | 0.3 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
0.1 | 1.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.3 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.1 | 1.9 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.4 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.1 | 0.9 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 1.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.9 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 1.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 1.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.2 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.1 | 0.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 0.3 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 0.4 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.4 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 0.8 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.5 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.1 | 1.4 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.1 | 0.8 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.1 | 1.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 1.4 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.3 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.2 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.1 | 0.5 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 0.6 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.3 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.1 | 0.2 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.1 | 2.7 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.8 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.3 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.1 | 1.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.3 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.1 | 1.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 1.3 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 1.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.0 | 0.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.7 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.2 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.2 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.0 | 0.3 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.0 | 0.2 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 1.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.2 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.5 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 2.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 0.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.4 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.2 | GO:0043295 | glutathione binding(GO:0043295) |
0.0 | 1.3 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 1.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.1 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.0 | 0.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 1.0 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.5 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.0 | 0.4 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 1.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.2 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.0 | 3.7 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.1 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.6 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.3 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.2 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.0 | 0.2 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.0 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.2 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.0 | 0.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.4 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.3 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.0 | 0.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 1.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 1.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.1 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.0 | 0.6 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.2 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.0 | 0.5 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.2 | GO:0015087 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.0 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.1 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.0 | 0.1 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.0 | 0.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.7 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.2 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 1.2 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.3 | GO:0035242 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.2 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.1 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.0 | 0.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 1.9 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 3.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 2.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 1.3 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 0.3 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 1.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 1.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.2 | GO:0098505 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) |
0.0 | 0.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 1.7 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 0.1 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.0 | 0.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.1 | GO:0004979 | beta-endorphin receptor activity(GO:0004979) morphine receptor activity(GO:0038047) |
0.0 | 0.2 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.3 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 1.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.5 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.5 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.7 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.6 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.3 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.0 | 0.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.2 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.6 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.2 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.4 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.0 | 1.7 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.0 | 0.3 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.3 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 1.3 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.3 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.7 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.1 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.1 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.0 | 0.2 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.7 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.1 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.0 | 0.7 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.3 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.0 | GO:0030109 | HLA-B specific inhibitory MHC class I receptor activity(GO:0030109) inhibitory MHC class I receptor activity(GO:0032396) |
0.0 | 0.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 1.9 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.2 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.4 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 0.1 | GO:0039552 | RIG-I binding(GO:0039552) |
0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.0 | GO:0050135 | NAD+ nucleosidase activity(GO:0003953) NAD(P)+ nucleosidase activity(GO:0050135) |
0.0 | 0.1 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.0 | 0.3 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.0 | 0.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.1 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.0 | 0.2 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.0 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.0 | 0.2 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.0 | 0.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.3 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.1 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.0 | 0.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 4.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.2 | 4.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 3.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 7.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 2.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 1.9 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 2.9 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 1.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 8.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.2 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 3.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 2.8 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.1 | 4.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 1.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 1.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 2.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 2.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 1.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 1.8 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 2.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 1.2 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.1 | 5.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 1.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 1.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 0.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 1.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.0 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 1.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 1.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 2.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 1.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 1.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 1.1 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 1.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.7 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 2.5 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 1.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 1.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 1.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.6 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.8 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 1.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.7 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 1.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 1.5 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 5.7 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 1.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.5 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.0 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.5 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.0 | 0.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.3 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 1.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |